E Villegas-Becerril, C Jimenez-Garcia, L A Perula-de Torres, M Espinosa-Calvo, C M Bueno-Serrano, F Romero-Ruperto, F Gines-Santiago, M C Moreno-Manzanaro, J J Muñoz-Gavilan, G Montes-Redondo, M A Quesada-Roman, M C Linares-Ramirez, J M Parras-Rejano, N Muñoz-Alcaraz, M D Maestre-Serrano, E M Romero-Rodriguez
OBJECTIVES: Radiation-induced dermatitis (RD) is one of the most common toxicities in radiation therapy (RT) patients. Corticosteroids, immunosuppressants, and natural products (NPs) have been used as treatment. The objective was to evaluate the efficacy of a NPs-based cream (Alantel®) to reduce the incidence of RD in women with breast cancer undergoing RT treatment. DESIGN: We conducted a controlled, randomized, double-blind clinical trial. SETTING: Radiation Oncology Unit of the Reina Sofía Hospital and 5 Primary Care centers of the Cordoba and Guadalquivir Health District (Spain)...
June 2024: Contemporary Clinical Trials Communications